Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

被引:0
|
作者
Jeffrey L Nordstrom
Sergey Gorlatov
Wenjun Zhang
Yinhua Yang
Ling Huang
Steve Burke
Hua Li
Valentina Ciccarone
Tengfei Zhang
Jeffrey Stavenhagen
Scott Koenig
Stanford J Stewart
Paul A Moore
Syd Johnson
Ezio Bonvini
机构
[1] MacroGenics,
[2] Inc.,undefined
[3] H. Lundbeck A/S,undefined
来源
关键词
Natural Killer Cell; Trastuzumab; Cynomolgus Monkey; ADCC Activity; Circulate Natural Killer Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
    Nordstrom, Jeffrey L.
    Gorlatov, Sergey
    Zhang, Wenjun
    Yang, Yinhua
    Huang, Ling
    Burke, Steve
    Li, Hua
    Ciccarone, Valentina
    Zhang, Tengfei
    Stavenhagen, Jeffrey
    Koenig, Scott
    Stewart, Stanford J.
    Moore, Paul A.
    Johnson, Syd
    Bonvini, Ezio
    BREAST CANCER RESEARCH, 2011, 13 (06)
  • [2] A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
    Yao, Xuejing
    Jiang, Jing
    Wang, Xin
    Huang, Changjiang
    Li, Dong
    Xie, Kuan
    Xu, Qiaoyu
    Li, Hongwen
    Li, Zhuanglin
    Lou, Liguang
    Fang, Jianmin
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 123 - 133
  • [3] A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
    Xuejing Yao
    Jing Jiang
    Xin Wang
    Changjiang Huang
    Dong Li
    Kuan Xie
    Qiaoyu Xu
    Hongwen Li
    Zhuanglin Li
    Liguang Lou
    Jianmin Fang
    Breast Cancer Research and Treatment, 2015, 153 : 123 - 133
  • [4] A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity
    Mohammadi, Mehdi
    Jeddi-Tehrani, Mahmood
    Golsaz-Shirazi, Forough
    Arjmand, Mohammad
    Torkashvand, Fatemeh
    Bahadori, Tannaz
    Judaki, Mohammad Ali
    Shiravi, Fariba
    Zare, Hengameh Ahmadi
    Haghighat, Farzaneh Notash
    Mobini, Maryam
    Shokri, Fazel
    Amiri, Mohammad Mehdi
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 121 - 131
  • [5] Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice
    Tsujie, Masanori
    Tsujie, Tomoko
    Toi, Hirofumi
    Uneda, Shima
    Shiozaki, Ken
    Tsai, Hilda
    Seon, Ben K.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2266 - 2273
  • [6] Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models
    Shiravi, Fariba
    Mohammadi, Mehdi
    Golsaz-Shirazi, Forough
    Bahadori, Tannaz
    Judaki, Mohammad Ali
    Fatemi, Forough
    Zare, Hengameh Ahmadi
    Haghighat, Farzaneh Notash
    Mobini, Maryam
    Jeddi-Tehrani, Mahmood
    Amiri, Mohammad Mehdi
    Shokri, Fazel
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 697 - 704
  • [7] Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models
    Fariba Shiravi
    Mehdi Mohammadi
    Forough Golsaz-Shirazi
    Tannaz Bahadori
    Mohammad Ali Judaki
    Forough Fatemi
    Hengameh Ahmadi Zare
    Farzaneh Notash Haghighat
    Maryam Mobini
    Mahmood Jeddi-Tehrani
    Mohammad Mehdi Amiri
    Fazel Shokri
    Investigational New Drugs, 2021, 39 : 697 - 704
  • [8] Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody
    Tej, Gullanki Naga Venkata Charan
    Neogi, Kaushik
    Nayak, Prasanta Kumar
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [9] Preclinical development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent anti-tumor activity
    Loo, Deryk T.
    Alderson, Ralph
    Chen, Francine
    Huang, Ling
    Zhang, Wenjun
    Gorlatov, Sergey
    Burke, Steve
    Ciccarone, Valentina
    Li, Hua
    Yang, Yinhua
    Son, Thomas
    Chen, Yan
    Li, Jonathan
    Rillema, Jill
    Licea, Monica
    Liang, Tony
    Mather, Jennie P.
    Koenig, Scott
    Stewart, Stanford J.
    Johnson, Syd
    Bonvini, Ezio
    Moore, Paul
    CANCER RESEARCH, 2012, 72
  • [10] A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action
    Zhang, Xuesai
    Chen, Jianhe
    Weng, Zhibing
    Li, Qingrou
    Zhao, Le
    Yu, Ning
    Deng, Lan
    Xu, Wei
    Yang, Yan
    Zhu, Zhenping
    Huang, Haomin
    MOLECULAR IMMUNOLOGY, 2020, 119 : 48 - 58